Abatacept
Abatacept may increase the immunosuppressive activities of Fingolimod.
Abetimus
Abetimus may increase the immunosuppressive activities of Fingolimod.
Abiraterone
The serum concentration of Fingolimod can be increased when it is combined with Abiraterone.
Advertisement
Acebutolol
Acebutolol may increase the bradycardic activities of Fingolimod.
Acetyl Sulfisoxazole
The metabolism of Fingolimod can be decreased when combined with Acetyl sulfisoxazole.
Adalimumab
Adalimumab may increase the immunosuppressive activities of Fingolimod.
Advertisement
Adefovir
Adefovir may increase the immunosuppressive activities of Fingolimod.
Ado-Trastuzumab Emtansine
Trastuzumab emtansine may increase the immunosuppressive activities of Fingolimod.
Ajmaline
Fingolimod may increase the arrhythmogenic activities of Ajmaline.
Advertisement
Alefacept
Alefacept may increase the immunosuppressive activities of Fingolimod.
Alemtuzumab
Alemtuzumab may increase the immunosuppressive activities of Fingolimod.
Alprenolol
Alprenolol may increase the bradycardic activities of Fingolimod.
Altretamine
Altretamine may increase the immunosuppressive activities of Fingolimod.
Amiodarone
Fingolimod may increase the arrhythmogenic activities of Amiodarone.
Amsacrine
Amsacrine may increase the immunosuppressive activities of Fingolimod.
Anagrelide
Fingolimod may increase the QTc-prolonging activities of Anagrelide.
Anakinra
Anakinra may increase the immunosuppressive activities of Fingolimod.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Fingolimod.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Fingolimod is combined with Anthrax immune globulin human.
Apalutamide
The serum concentration of Fingolimod can be decreased when it is combined with Apalutamide.
Apremilast
Apremilast may increase the immunosuppressive activities of Fingolimod.
Aprepitant
The serum concentration of Fingolimod can be increased when it is combined with Aprepitant.
Arsenic Trioxide
Fingolimod may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Fingolimod may increase the QTc-prolonging activities of Artemether.
Atazanavir
The metabolism of Fingolimod can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the bradycardic activities of Fingolimod.
Atomoxetine
The metabolism of Fingolimod can be decreased when combined with Atomoxetine.
Azacitidine
Azacitidine may increase the immunosuppressive activities of Fingolimod.
Azathioprine
Azathioprine may increase the immunosuppressive activities of Fingolimod.
Azithromycin
Fingolimod may increase the QTc-prolonging activities of Azithromycin.
Basiliximab
Basiliximab may increase the immunosuppressive activities of Fingolimod.
BCG Vaccine
The risk or severity of adverse effects can be increased when Fingolimod is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Bacillus calmette-guerin substrain tice live antigen.
Bedaquiline
Fingolimod may increase the QTc-prolonging activities of Bedaquiline.
Belatacept
Belatacept may increase the immunosuppressive activities of Fingolimod.
Belimumab
Belimumab may increase the immunosuppressive activities of Fingolimod.
Bendroflumethiazide
Bendroflumethiazide may increase the bradycardic activities of Fingolimod.
Benznidazole
Benznidazole may increase the immunosuppressive activities of Fingolimod.
Beractant
Beractant may increase the bradycardic activities of Fingolimod.
Betamethasone
Betamethasone may increase the immunosuppressive activities of Fingolimod.
Betaxolol
Betaxolol may increase the bradycardic activities of Fingolimod.
Bisoprolol
Bisoprolol may increase the bradycardic activities of Fingolimod.
Bleomycin
Bleomycin may increase the immunosuppressive activities of Fingolimod.
Blinatumomab
Blinatumomab may increase the immunosuppressive activities of Fingolimod.
Boceprevir
The metabolism of Fingolimod can be decreased when combined with Boceprevir.
Bopindolol
Bopindolol may increase the bradycardic activities of Fingolimod.
Bortezomib
The metabolism of Fingolimod can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Fingolimod can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Fingolimod can be decreased when it is combined with Bosentan.
Brentuximab Vedotin
Brentuximab vedotin may increase the immunosuppressive activities of Fingolimod.
Bretylium
Bretylium may increase the bradycardic activities of Fingolimod.
Brodalumab
Brodalumab may increase the immunosuppressive activities of Fingolimod.
Budesonide
Budesonide may increase the immunosuppressive activities of Fingolimod.
Bupranolol
Bupranolol may increase the bradycardic activities of Fingolimod.
Bupropion
The metabolism of Fingolimod can be decreased when combined with Bupropion.
Busulfan
Busulfan may increase the immunosuppressive activities of Fingolimod.
C1 esterase inhibitor (human)
Human C1-esterase inhibitor may increase the immunosuppressive activities of Fingolimod.
Cabazitaxel
Cabazitaxel may increase the immunosuppressive activities of Fingolimod.
Calfactant
Calfactant may increase the bradycardic activities of Fingolimod.
Canakinumab
Canakinumab may increase the immunosuppressive activities of Fingolimod.
Capecitabine
Capecitabine may increase the immunosuppressive activities of Fingolimod.
Carbamazepine
The serum concentration of Fingolimod can be decreased when it is combined with Carbamazepine.
Carboplatin
Carboplatin may increase the immunosuppressive activities of Fingolimod.
Carmustine
Carmustine may increase the immunosuppressive activities of Fingolimod.
Carteolol
Carteolol may increase the bradycardic activities of Fingolimod.
Carvedilol
Carvedilol may increase the bradycardic activities of Fingolimod.
Celecoxib
The metabolism of Fingolimod can be decreased when combined with Celecoxib.
Celiprolol
Celiprolol may increase the bradycardic activities of Fingolimod.
Ceritinib
Fingolimod may increase the bradycardic activities of Ceritinib.
Certolizumab Pegol
Certolizumab pegol may increase the immunosuppressive activities of Fingolimod.
Chlorambucil
Chlorambucil may increase the immunosuppressive activities of Fingolimod.
Chloroquine
The metabolism of Fingolimod can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Fingolimod can be decreased when combined with Chlorpromazine.
Cholecalciferol
The metabolism of Fingolimod can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Fingolimod can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Fingolimod can be decreased when combined with Cinacalcet.
Ciprofloxacin
Fingolimod may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Fingolimod may increase the QTc-prolonging activities of Cisapride.
Cisplatin
Cisplatin may increase the immunosuppressive activities of Fingolimod.
Citalopram
Fingolimod may increase the QTc-prolonging activities of Citalopram.
Cladribine
Cladribine may increase the immunosuppressive activities of Fingolimod.
Clarithromycin
The metabolism of Fingolimod can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Fingolimod can be decreased when combined with Clemastine.
Clobazam
The metabolism of Fingolimod can be decreased when combined with Clobazam.
Clofarabine
Clofarabine may increase the immunosuppressive activities of Fingolimod.
Clomipramine
The metabolism of Fingolimod can be decreased when combined with Clomipramine.
Clonidine
Clonidine may increase the bradycardic activities of Fingolimod.
Clotrimazole
The metabolism of Fingolimod can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Fingolimod can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Fingolimod can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Fingolimod can be decreased when combined with Cocaine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Fingolimod.
Corticotropin
Corticotropin may increase the immunosuppressive activities of Fingolimod.
Cortisone Acetate
Cortisone acetate may increase the immunosuppressive activities of Fingolimod.
Crizotinib
The metabolism of Fingolimod can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Fingolimod can be decreased when combined with Curcumin.
Cyclophosphamide
Cyclophosphamide may increase the immunosuppressive activities of Fingolimod.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the immunosuppressive activities of Fingolimod.
Cyclosporine
Cyclosporine may increase the immunosuppressive activities of Fingolimod.
Cyproterone Acetate
The serum concentration of Fingolimod can be decreased when it is combined with Cyproterone acetate.
Cytarabine
Cytarabine may increase the immunosuppressive activities of Fingolimod.
Dabrafenib
The serum concentration of Fingolimod can be decreased when it is combined with Dabrafenib.
Dacarbazine
Dacarbazine may increase the immunosuppressive activities of Fingolimod.
Daclizumab
Daclizumab may increase the immunosuppressive activities of Fingolimod.
Dactinomycin
Dactinomycin may increase the immunosuppressive activities of Fingolimod.
Darifenacin
The metabolism of Fingolimod can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Fingolimod can be increased when it is combined with Darunavir.
Dasatinib
Dasatinib may increase the immunosuppressive activities of Fingolimod.
Dasatinib Anhydrous
Dasatinib may increase the immunosuppressive activities of Fingolimod.
Daunorubicin
Daunorubicin may increase the immunosuppressive activities of Fingolimod.
Deferasirox
The serum concentration of Fingolimod can be decreased when it is combined with Deferasirox.
Deflazacort
Deflazacort may increase the immunosuppressive activities of Fingolimod.
Delavirdine
The metabolism of Fingolimod can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Fingolimod.
Desipramine
Desipramine may increase the bradycardic activities of Fingolimod.
Dexamethasone
Dexamethasone may increase the immunosuppressive activities of Fingolimod.
Dexmedetomidine
Dexmedetomidine may increase the bradycardic activities of Fingolimod.
Digoxin
Digoxin may increase the bradycardic activities of Fingolimod.
Dihydroergotamine
The metabolism of Fingolimod can be decreased when combined with Dihydroergotamine.
Diltiazem
The risk or severity of bradycardia can be increased when Diltiazem is combined with Fingolimod.
Dimethyl Fumarate
Dimethyl fumarate may increase the immunosuppressive activities of Fingolimod.
Dinutuximab
Dinutuximab may increase the immunosuppressive activities of Fingolimod.
Diphenhydramine
The metabolism of Fingolimod can be decreased when combined with Diphenhydramine.
Disopyramide
Fingolimod may increase the arrhythmogenic activities of Disopyramide.
Docetaxel
Docetaxel may increase the immunosuppressive activities of Fingolimod.
DOCETAXEL ANHYDROUS
Docetaxel may increase the immunosuppressive activities of Fingolimod.
Dofetilide
Fingolimod may increase the arrhythmogenic activities of Dofetilide.
Dolasetron
Fingolimod may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Fingolimod may increase the QTc-prolonging activities of Domperidone.
Donepezil
Donepezil may increase the bradycardic activities of Fingolimod.
Dothiepin
The metabolism of Fingolimod can be decreased when combined with Dosulepin.
Doxorubicin
Doxorubicin may increase the immunosuppressive activities of Fingolimod.
Doxorubicin Hydrochloride
Doxorubicin may increase the immunosuppressive activities of Fingolimod.
Doxycycline
The metabolism of Fingolimod can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Fingolimod can be decreased when combined with Doxycycline.
Dronedarone
Fingolimod may increase the arrhythmogenic activities of Dronedarone.
Droperidol
Fingolimod may increase the QTc-prolonging activities of Droperidol.
Duloxetine
The metabolism of Fingolimod can be decreased when combined with Duloxetine.
Eculizumab
Eculizumab may increase the immunosuppressive activities of Fingolimod.
Efalizumab
Efalizumab may increase the immunosuppressive activities of Fingolimod.
Eliglustat
Fingolimod may increase the QTc-prolonging activities of Eliglustat.
Enzalutamide
The serum concentration of Fingolimod can be decreased when it is combined with Enzalutamide.
Epirubicin
Epirubicin may increase the immunosuppressive activities of Fingolimod.
Erythromycin
The metabolism of Fingolimod can be decreased when combined with Erythromycin.
Escitalopram
Fingolimod may increase the QTc-prolonging activities of Escitalopram.
Esmolol
Esmolol may increase the bradycardic activities of Fingolimod.
Estramustine
Estramustine may increase the immunosuppressive activities of Fingolimod.
Etanercept
Etanercept may increase the immunosuppressive activities of Fingolimod.
Etoposide
Etoposide may increase the immunosuppressive activities of Fingolimod.
Everolimus
Everolimus may increase the immunosuppressive activities of Fingolimod.
Flecainide
Fingolimod may increase the QTc-prolonging activities of Flecainide.
Floxuridine
Floxuridine may increase the immunosuppressive activities of Fingolimod.
Fluconazole
The metabolism of Fingolimod can be decreased when combined with Fluconazole.
Fludarabine
Fludarabine may increase the immunosuppressive activities of Fingolimod.
Fludrocortisone
Fludrocortisone may increase the immunosuppressive activities of Fingolimod.
Fluorouracil
Fluorouracil may increase the immunosuppressive activities of Fingolimod.
Fluoxetine
The metabolism of Fingolimod can be decreased when combined with Fluoxetine.
Flupenthixol
Fingolimod may increase the QTc-prolonging activities of Flupentixol.
Fluvoxamine
The metabolism of Fingolimod can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Fingolimod can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Fingolimod can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Fingolimod can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Fingolimod can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Fingolimod can be increased when it is combined with Fusidic Acid.
Gadobenate
Fingolimod may increase the QTc-prolonging activities of Gadobenic acid.
Galantamine
Galantamine may increase the bradycardic activities of Fingolimod.
Gallium Nitrate
Gallium nitrate may increase the immunosuppressive activities of Fingolimod.
Gemcitabine
Gemcitabine may increase the immunosuppressive activities of Fingolimod.
Gemifloxacin
Fingolimod may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Fingolimod may increase the QTc-prolonging activities of Gemifloxacin.
Gemtuzumab ozogamicin
Gemtuzumab ozogamicin may increase the immunosuppressive activities of Fingolimod.
Glatiramer
Glatiramer Acetate may increase the immunosuppressive activities of Fingolimod.
Glimepiride
Glimepiride may increase the immunosuppressive activities of Fingolimod.
Golimumab
Golimumab may increase the immunosuppressive activities of Fingolimod.
Goserelin
Fingolimod may increase the QTc-prolonging activities of Goserelin.
Granisetron
Fingolimod may increase the QTc-prolonging activities of Granisetron.
Guanfacine
Guanfacine may increase the bradycardic activities of Fingolimod.
Haloperidol
The metabolism of Fingolimod can be decreased when combined with Haloperidol.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Fingolimod is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Fingolimod is combined with Hepatitis B Vaccine (Recombinant).
Hydrocortisone
Hydrocortisone may increase the immunosuppressive activities of Fingolimod.
Hydroxyurea
Hydroxyurea may increase the immunosuppressive activities of Fingolimod.
Hypericin
Hypericin may increase the immunosuppressive activities of Fingolimod.
Hypoxis hemerocallidea root extract
The serum concentration of Fingolimod can be decreased when it is combined with St. John's Wort.
Ibritumomab Tiuxetan
Ibritumomab tiuxetan may increase the immunosuppressive activities of Fingolimod.
Ibrutinib
Ibrutinib may increase the immunosuppressive activities of Fingolimod.
Ibutilide
Fingolimod may increase the arrhythmogenic activities of Ibutilide.
Icatibant
Icatibant may increase the immunosuppressive activities of Fingolimod.
Idarubicin
Idarubicin may increase the immunosuppressive activities of Fingolimod.
Idelalisib
Idelalisib may increase the immunosuppressive activities of Fingolimod.
Ifosfamide
Ifosfamide may increase the immunosuppressive activities of Fingolimod.
Iloperidone
Fingolimod may increase the QTc-prolonging activities of Iloperidone.
Imatinib
Imatinib may increase the immunosuppressive activities of Fingolimod.
Imipramine
The metabolism of Fingolimod can be decreased when combined with Imipramine.
Imiquimod
Imiquimod may increase the immunosuppressive activities of Fingolimod.
Indinavir
The metabolism of Fingolimod can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Fingolimod can be decreased when combined with Indinavir.
Infliximab
Infliximab may increase the immunosuppressive activities of Fingolimod.
Infliximab-Abda
Infliximab may increase the immunosuppressive activities of Fingolimod.
Infliximab-Dyyb
Infliximab may increase the immunosuppressive activities of Fingolimod.
Irinotecan
Irinotecan may increase the immunosuppressive activities of Fingolimod.
Isavuconazole
The serum concentration of Fingolimod can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Fingolimod can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Fingolimod can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Fingolimod can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Fingolimod can be decreased when combined with Itraconazole.
Ivabradine
Fingolimod may increase the bradycardic activities of Ivabradine.
Ivacaftor
The serum concentration of Fingolimod can be increased when it is combined with Ivacaftor.
Ketoconazole
The serum concentration of the active metabolites of Fingolimod can be increased when Fingolimod is used in combination with Ketoconazole.
Labetalol
Labetalol may increase the bradycardic activities of Fingolimod.
Lacosamide
Fingolimod may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Lanreotide may increase the bradycardic activities of Fingolimod.
Leflunomide
The risk or severity of adverse effects can be increased when Fingolimod is combined with Leflunomide.
Lenalidomide
Lenalidomide may increase the immunosuppressive activities of Fingolimod.
Lenvatinib
Fingolimod may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Fingolimod may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Fingolimod may increase the QTc-prolonging activities of Leuprolide.
Levobetaxolol
Levobetaxolol may increase the bradycardic activities of Fingolimod.
Levobunolol
Levobunolol may increase the bradycardic activities of Fingolimod.
Levofloxacin
Fingolimod may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Fingolimod may increase the QTc-prolonging activities of Levofloxacin.
Lomustine
Lomustine may increase the immunosuppressive activities of Fingolimod.
Lopinavir
The metabolism of Fingolimod can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Fingolimod can be decreased when combined with Lorcaserin.
Lovastatin
The metabolism of Fingolimod can be decreased when combined with Lovastatin.
Lucinactant
Lucinactant may increase the bradycardic activities of Fingolimod.
Luliconazole
The serum concentration of Fingolimod can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Fingolimod can be increased when combined with Lumacaftor.
Lumefantrine
Fingolimod may increase the QTc-prolonging activities of Lumefantrine.
Manidipine
The metabolism of Fingolimod can be decreased when combined with Manidipine.
Mechlorethamine
Mechlorethamine may increase the immunosuppressive activities of Fingolimod.
Melphalan
Melphalan may increase the immunosuppressive activities of Fingolimod.
Mepindolol
Mepindolol may increase the bradycardic activities of Fingolimod.
Mepolizumab
Mepolizumab may increase the immunosuppressive activities of Fingolimod.
Mercaptopurine
Mercaptopurine may increase the immunosuppressive activities of Fingolimod.
MERCAPTOPURINE ANHYDROUS
Mercaptopurine may increase the immunosuppressive activities of Fingolimod.
Methadone
The metabolism of Fingolimod can be decreased when combined with Methadone.
Methotrexate
Methotrexate may increase the immunosuppressive activities of Fingolimod.
Methotrimeprazine
The metabolism of Fingolimod can be decreased when combined with Methotrimeprazine.
Methyldopa
Methyldopa may increase the bradycardic activities of Fingolimod.
METHYLDOPA ANHYDROUS
Methyldopa may increase the bradycardic activities of Fingolimod.
Methylprednisolone
Methylprednisolone may increase the immunosuppressive activities of Fingolimod.
Metipranolol
Metipranolol may increase the bradycardic activities of Fingolimod.
Metoprolol
Metoprolol may increase the bradycardic activities of Fingolimod.
Midostaurin
The metabolism of Fingolimod can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Fingolimod can be increased when it is combined with Mifepristone.
Mirabegron
The metabolism of Fingolimod can be decreased when combined with Mirabegron.
Mitomycin
Mitomycin may increase the immunosuppressive activities of Fingolimod.
Mitotane
The serum concentration of Fingolimod can be decreased when it is combined with Mitotane.
Mitoxantrone
Mitoxantrone may increase the immunosuppressive activities of Fingolimod.
Moxifloxacin
Fingolimod may increase the QTc-prolonging activities of Moxifloxacin.
Muromonab-CD3
Muromonab may increase the immunosuppressive activities of Fingolimod.
MYCOPHENOLATE
Mycophenolic acid may increase the immunosuppressive activities of Fingolimod.
Mycophenolate Mofetil
Mycophenolate mofetil may increase the immunosuppressive activities of Fingolimod.
Mycophenolic Acid
Mycophenolic acid may increase the immunosuppressive activities of Fingolimod.
Nadolol
Nadolol may increase the bradycardic activities of Fingolimod.
Natalizumab
The risk or severity of adverse effects can be increased when Fingolimod is combined with Natalizumab.
Nebivolol
Nebivolol may increase the bradycardic activities of Fingolimod.
Nefazodone
The metabolism of Fingolimod can be decreased when combined with Nefazodone.
Nelarabine
Nelarabine may increase the immunosuppressive activities of Fingolimod.
Nelfinavir
The metabolism of Fingolimod can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Fingolimod can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Fingolimod can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Fingolimod can be decreased when combined with Nicardipine.
Nicotine
The metabolism of Fingolimod can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Fingolimod can be decreased when combined with Nicotine.
Nilotinib
Nilotinib may increase the immunosuppressive activities of Fingolimod.
Obinutuzumab
Obinutuzumab may increase the immunosuppressive activities of Fingolimod.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Fingolimod.
Octreotide
Octreotide may increase the bradycardic activities of Fingolimod.
Ofloxacin
Fingolimod may increase the QTc-prolonging activities of Ofloxacin.
Olaparib
The metabolism of Fingolimod can be decreased when combined with Olaparib.
Ondansetron
Fingolimod may increase the QTc-prolonging activities of Ondansetron.
Osimertinib
The serum concentration of Fingolimod can be increased when it is combined with Osimertinib.
Oxaliplatin
Oxaliplatin may increase the immunosuppressive activities of Fingolimod.
Oxprenolol
Oxprenolol may increase the bradycardic activities of Fingolimod.
Paclitaxel
Paclitaxel may increase the immunosuppressive activities of Fingolimod.
Palbociclib
Palbociclib may increase the immunosuppressive activities of Fingolimod.
Paliperidone
Fingolimod may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
The serum concentration of Fingolimod can be increased when it is combined with Panobinostat.
Paroxetine
The metabolism of Fingolimod can be decreased when combined with Paroxetine.
Pasireotide
Pasireotide may increase the bradycardic activities of Fingolimod.
Pazopanib
Pazopanib may increase the immunosuppressive activities of Fingolimod.
Pegaspargase
Pegaspargase may increase the immunosuppressive activities of Fingolimod.
Peginterferon Alfa-2b
The serum concentration of Fingolimod can be decreased when it is combined with Peginterferon alfa-2b.
Pemetrexed
Pemetrexed may increase the immunosuppressive activities of Fingolimod.
Penbutolol
Penbutolol may increase the bradycardic activities of Fingolimod.
Pentamidine
Fingolimod may increase the QTc-prolonging activities of Pentamidine.
Pentobarbital
The metabolism of Fingolimod can be increased when combined with Pentobarbital.
Pentostatin
Pentostatin may increase the immunosuppressive activities of Fingolimod.
Perflutren
Fingolimod may increase the QTc-prolonging activities of Perflutren.
Phenobarbital
The metabolism of Fingolimod can be increased when combined with Phenobarbital.
Phenylalanine
L-Phenylalanine may increase the immunosuppressive activities of Fingolimod.
Phenytoin
The metabolism of Fingolimod can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fingolimod.
Pimozide
Fingolimod may increase the QTc-prolonging activities of Pimozide.
Pindolol
Pindolol may increase the bradycardic activities of Fingolimod.
Pirarubicin
Pirarubicin may increase the immunosuppressive activities of Fingolimod.
Pirfenidone
Pirfenidone may increase the immunosuppressive activities of Fingolimod.
Pomalidomide
Pomalidomide may increase the immunosuppressive activities of Fingolimod.
Poractant alfa
Fingolimod may increase the bradycardic activities of Poractant alfa.
Posaconazole
The metabolism of Fingolimod can be decreased when combined with Posaconazole.
Practolol
Practolol may increase the bradycardic activities of Fingolimod.
Pralatrexate
Pralatrexate may increase the immunosuppressive activities of Fingolimod.
Prednisolone
Prednisolone may increase the immunosuppressive activities of Fingolimod.
Prednisone
Prednisone may increase the immunosuppressive activities of Fingolimod.
Primaquine
Fingolimod may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Fingolimod can be increased when combined with Primidone.
Procainamide
Fingolimod may increase the arrhythmogenic activities of Procainamide.
Procarbazine
Procarbazine may increase the immunosuppressive activities of Fingolimod.
Promazine
The metabolism of Fingolimod can be decreased when combined with Promazine.
Propafenone
Propafenone may increase the bradycardic activities of Fingolimod.
Propranolol
Propranolol may increase the bradycardic activities of Fingolimod.
Quetiapine
Fingolimod may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Fingolimod may increase the QTc-prolonging activities of Quetiapine.
Quinidine
Fingolimod may increase the arrhythmogenic activities of Quinidine.
Quinine
Fingolimod may increase the QTc-prolonging activities of Quinine.
Rabbit anti-human T-lymphocyte globulin
Antithymocyte immunoglobulin (rabbit) may increase the immunosuppressive activities of Fingolimod.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Fingolimod is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Rabies virus inactivated antigen, A.
Ranolazine
The metabolism of Fingolimod can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Fingolimod can be increased when combined with Rifabutin.
Rifampin
The metabolism of Fingolimod can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Fingolimod can be increased when combined with Rifapentine.
Rilonacept
Rilonacept may increase the immunosuppressive activities of Fingolimod.
Ritonavir
The metabolism of Fingolimod can be decreased when combined with Ritonavir.
Rituximab
Rituximab may increase the immunosuppressive activities of Fingolimod.
Rivastigmine
Rivastigmine may increase the bradycardic activities of Fingolimod.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Fingolimod.
Rolapitant
The metabolism of Fingolimod can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Fingolimod can be decreased when combined with Ropinirole.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Fingolimod is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Fingolimod is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Fingolimod can be decreased when combined with Rucaparib.
Ruxolitinib
Ruxolitinib may increase the immunosuppressive activities of Fingolimod.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Fingolimod is combined with Salmonella typhi ty21a live antigen.
Saquinavir
The metabolism of Fingolimod can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Fingolimod can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Sarilumab.
Secukinumab
Secukinumab may increase the immunosuppressive activities of Fingolimod.
Sertraline
The metabolism of Fingolimod can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Fingolimod can be decreased when combined with Sildenafil.
Siltuximab
Siltuximab may increase the immunosuppressive activities of Fingolimod.
Simeprevir
The serum concentration of Fingolimod can be increased when it is combined with Simeprevir.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fingolimod.
Sirolimus
Sirolimus may increase the immunosuppressive activities of Fingolimod.
Sorafenib
Sorafenib may increase the immunosuppressive activities of Fingolimod.
Sotalol
Sotalol may increase the bradycardic activities of Fingolimod.
ST. JOHN'S WORT EXTRACT
The serum concentration of Fingolimod can be decreased when it is combined with St. John's Wort.
Streptozocin
Streptozocin may increase the immunosuppressive activities of Fingolimod.
Sufentanil
Sufentanil may increase the bradycardic activities of Fingolimod.
Sulfisoxazole
The metabolism of Fingolimod can be decreased when combined with Sulfisoxazole.
Sunitinib
Sunitinib may increase the immunosuppressive activities of Fingolimod.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Fingolimod.
Talinolol
Talinolol may increase the bradycardic activities of Fingolimod.
Telaprevir
The metabolism of Fingolimod can be decreased when combined with Telaprevir.
Telavancin
Fingolimod may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Fingolimod can be decreased when combined with Telithromycin.
Temozolomide
Temozolomide may increase the immunosuppressive activities of Fingolimod.
Temsirolimus
Temsirolimus may increase the immunosuppressive activities of Fingolimod.
Teniposide
Teniposide may increase the immunosuppressive activities of Fingolimod.
Terbinafine
The metabolism of Fingolimod can be decreased when combined with Terbinafine.
Terbutaline
Terbutaline may increase the bradycardic activities of Fingolimod.
Terbutaline Sulfate
Terbutaline may increase the bradycardic activities of Fingolimod.
Teriflunomide
Teriflunomide may increase the immunosuppressive activities of Fingolimod.
Tertatolol
Tertatolol may increase the bradycardic activities of Fingolimod.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Fingolimod is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tetrabenazine
Fingolimod may increase the QTc-prolonging activities of Tetrabenazine.
Thalidomide
Thalidomide may increase the immunosuppressive activities of Fingolimod.
Thioguanine
Tioguanine may increase the immunosuppressive activities of Fingolimod.
Thioguanine Anhydrous
Tioguanine may increase the immunosuppressive activities of Fingolimod.
Thioridazine
The metabolism of Fingolimod can be decreased when combined with Thioridazine.
Thiotepa
Thiotepa may increase the immunosuppressive activities of Fingolimod.
Thymocyte Immunoglobulin, Equine
Antilymphocyte immunoglobulin (horse) may increase the immunosuppressive activities of Fingolimod.
Ticlopidine
The metabolism of Fingolimod can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the bradycardic activities of Fingolimod.
Timolol Anhydrous
Timolol may increase the bradycardic activities of Fingolimod.
Tipranavir
The metabolism of Fingolimod can be decreased when combined with Tipranavir.
Tizanidine
Tizanidine may increase the bradycardic activities of Fingolimod.
Tocilizumab
Tocilizumab may increase the immunosuppressive activities of Fingolimod.
Tofacitinib
Fingolimod may increase the immunosuppressive activities of Tofacitinib.
Topotecan
Topotecan may increase the immunosuppressive activities of Fingolimod.
Toremifene
Fingolimod may increase the QTc-prolonging activities of Toremifene.
Tositumomab
Tositumomab may increase the immunosuppressive activities of Fingolimod.
Trabectedin
Trabectedin may increase the immunosuppressive activities of Fingolimod.
Tranylcypromine
The metabolism of Fingolimod can be decreased when combined with Tranylcypromine.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Fingolimod.
Tretinoin
Tretinoin may increase the immunosuppressive activities of Fingolimod.
Triamcinolone
Triamcinolone may increase the immunosuppressive activities of Fingolimod.
Trofosfamide
Trofosfamide may increase the immunosuppressive activities of Fingolimod.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Fingolimod is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Ustekinumab
Ustekinumab may increase the immunosuppressive activities of Fingolimod.
Vandetanib
Fingolimod may increase the QTc-prolonging activities of Vandetanib.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vedolizumab
Vedolizumab may increase the immunosuppressive activities of Fingolimod.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Fingolimod.
Venlafaxine
The metabolism of Fingolimod can be decreased when combined with Venlafaxine.
Verapamil
The risk or severity of bradycardia can be increased when Verapamil is combined with Fingolimod.
Vilanterol
Vilanterol may increase the immunosuppressive activities of Fingolimod.
Vinblastine
Vinblastine may increase the immunosuppressive activities of Fingolimod.
Vincristine
Vincristine may increase the immunosuppressive activities of Fingolimod.
Vindesine
Vindesine may increase the immunosuppressive activities of Fingolimod.
Vinorelbine
Vinorelbine may increase the immunosuppressive activities of Fingolimod.
Voriconazole
The metabolism of Fingolimod can be decreased when combined with Voriconazole.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Fingolimod is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Fingolimod is combined with Yellow Fever Vaccine.
Ziprasidone
Fingolimod may increase the QTc-prolonging activities of Ziprasidone.
Zuclopenthixol
Fingolimod may increase the QTc-prolonging activities of Zuclopenthixol.
